Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.

@article{Sasse2007ChemoimmunotherapyVC,
  title={Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.},
  author={Andre Deeke Sasse and Emma Chen Sasse and Luciana Gontijo de Oliveira Clark and L. Fernando Ulloa and Ot{\'a}vio Augusto Camara Clark},
  journal={The Cochrane database of systematic reviews},
  year={2007},
  volume={1},
  pages={CD005413}
}
BACKGROUND Malignant melanoma, one of the most aggressive of all skin cancers, is increasing in incidence throughout the world. Surgery remains the cornerstone of curative treatment in earlier stages. Metastatic disease is incurable in most affected people, because melanoma does not respond to most systemic treatments. A number of novel approaches are under evaluation and have shown promising results, but they are usually associated with increased toxicity and cost. The combination of… CONTINUE READING